Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: LY3053102
Total 2 results
Eli Lilly and Company
Completed
A Study of LY3053102 in Healthy Participants
Healthy Volunteers
Singapore
Eli Lilly and Company
Terminated
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Type 2 Diabetes Mellitus
United States
Sponsors and Collaborators
Xiao-Ming Mao
Royal Hobart Hospital Research Foundation (funding source)
Friedrich Miescher Institute for Biomedical Research (FMI)
Kerstyn C. Zalesin, M.D.
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Only For Children Pharmaceuticals
Kuwait University
Biorobotic Institute Scuola Superiore sant'Anna Pisa
Genuv Inc.
Hopeful Aging
Marcus Vinícius Guimarães de Lacerda
Jia Liu
Hoersholm Hospital
Egyptian Russian University
Liming Cheng
Pancreatic Cancer UK
The People's Hospital of Guangxi Zhang Autonomous Region
Sahar Salehi
Van Boven, Robert W., M.D.
Klinikum Bad Woerishofen
View Full List
Medical Conditions
Non-malignant Chronic Pain
Non Alcoholic Fatty Liver
Elderly Residents
Pediatric Progressive Low-grade Gliomas
Type A Aortic Dissection
Therapy Resistant Depression
Hepatic Enzymes
Rigid Spine Syndrome
Left Ventricular Ejection Fraction Less Then or Equal to 50percent
Hypno-breastfeeding Education
Adenocarcinoma of Lung Stage IIIB
Dermatitis, Adverse Drug Reaction
Chronic Lymphocytic Leukemia (CLL)
Asthma and Allergic Rhinitis
Febrile Convulsion
Counterstrain
Appendix Tumor
Anal Intraepithelial Neoplasia 2
Social Skill Training Group
Acquired Hypogonadotropic Hypogonadism
View Full List
Drug Interventions
ACP-204
IBI318
High-dose loop diuretics
Nystatin
CAZ/AVI plus Aztreonam
Olopatadine hydrochloride ophthalmic solution 0.7%)
APD334
MC-1101
RDEA3170 12 mg
Jatenzo
Vehicle Foam with UVA and UVB and visible light irradiation
Omalizumab Injection
LX4211 800 mg
Naltrexone and bupropion SR
P276-00
Ibudilast
Androgen-deprivation Therapy (ADT)
Iohexol Inj 300 MG/ML
Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U
Ustekinumab
View Full List
CROs by country
Contract Research Organizations in Armenia
Contract Research Organizations in Bahamas
Contract Research Organizations in Cyprus
Contract Research Organizations in Macedonia
Contract Research Organizations in Malta
Contract Research Organizations in Mexico
Contract Research Organizations in Morocco
Contract Research Organizations in Oman
Contract Research Organizations in Peru
Contract Research Organizations in Philippines
Contract Research Organizations in Portugal
Contract Research Organizations in Serbia
Contract Research Organizations in South Korea
CRO list by country
CROs in Papua New Guinea
SGS
All CROs in Papua New Guinea
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe